Status:
COMPLETED
Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep
Lead Sponsor:
Centre Francois Baclesse
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Breast Cancer
Memory Disorders
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The results of this study will contribute to a better understanding of prospective memory deficit processes in breast cancer in relation to sleep disorders frequently reported in this pathology. In th...
Eligibility Criteria
Inclusion
- Major patients under the age of 70;
- Patients who have been treated by surgery or radiotherapy for non-metastatic breast cancer
- Radiotherapy completed for about 6 months
- Level of study 3 "end of primary studies" minimum (Barbizet scale);
- French mother tongue;
- Menopausal women for at least 1 year before the selection visit
- Absence of primary cancer of the central nervous system or brain metastases;
- Absence of previous neurological damage;
- Absence of personality disorders and progressive psychiatric pathology;
- Having signed the informed consent to participate in the study.
Exclusion
- Primary cancer other than breast
- Metastatic cancer
- Treated by chemotherapy
- Cognitive function disorders pre-existing to cancer diagnosis
- Patients with paraneoplastic syndrome;
- Evolutionary psychiatric pathology;
- Refusal of participation;
- Patients unable to respond to cognitive tests;
- Drug use or excessive consumption of alcohol.
Key Trial Info
Start Date :
January 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2020
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03420105
Start Date
January 5 2018
End Date
March 6 2020
Last Update
March 9 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre François Baclesse
Caen, France, 14076
2
Inserm-Ephe-Unicaen U1077 (
Caen, France